XML 17 R7.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Common stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Noncontrolling Interest in Subsidiary
Total
Beginning balance at Dec. 31, 2019 $ 20 $ 1,203,186 $ (668,232) $ (1,566) $ 9,621 $ 543,029
Beginning balance (in shares) at Dec. 31, 2019 204,723,055          
Increase (Decrease) in Stockholders' Equity            
Issuance of common stock   194       194
Issuance of common stock (in shares) 871,010          
Repurchase of common stock   (4,244)       (4,244)
Repurchase of common stock (in shares) (2,810,449)          
Stock-based compensation   1,054       1,054
Net income (loss)     1,704   (805) 899
Other comprehensive income (loss)       (1,915)   (1,915)
Increase in ownership in subsidiary   (1,388)     1,388  
Ending balance at Mar. 31, 2020 $ 20 1,198,802 (666,528) (3,481) 10,204 539,017
Ending balance (in shares) at Mar. 31, 2020 202,783,616          
Beginning balance at Dec. 31, 2019 $ 20 1,203,186 (668,232) (1,566) 9,621 543,029
Beginning balance (in shares) at Dec. 31, 2019 204,723,055          
Increase (Decrease) in Stockholders' Equity            
Net income (loss)         (1,106) (6,138)
Other comprehensive income (loss)           (909)
Ending balance at Jun. 30, 2020 $ 20 1,193,197 (673,264) (2,475) 9,903 527,381
Ending balance (in shares) at Jun. 30, 2020 199,506,780          
Beginning balance at Mar. 31, 2020 $ 20 1,198,802 (666,528) (3,481) 10,204 539,017
Beginning balance (in shares) at Mar. 31, 2020 202,783,616          
Increase (Decrease) in Stockholders' Equity            
Issuance of common stock   41       41
Issuance of common stock (in shares) 25,214          
Repurchase of common stock   (6,406)       (6,406)
Repurchase of common stock (in shares) (3,302,050)          
Stock-based compensation   760       760
Net income (loss)     (6,736)   (301) (7,037)
Other comprehensive income (loss)       1,006   1,006
Ending balance at Jun. 30, 2020 $ 20 1,193,197 (673,264) (2,475) 9,903 527,381
Ending balance (in shares) at Jun. 30, 2020 199,506,780          
Beginning balance at Dec. 31, 2020 $ 20 1,191,791 (678,096) (209) 9,344 $ 522,850
Beginning balance (in shares) at Dec. 31, 2020 198,491,204         198,491,204
Increase (Decrease) in Stockholders' Equity            
Issuance of common stock   3,216       $ 3,216
Issuance of common stock (in shares) 1,323,814          
Stock-based compensation   3,367       3,367
Net income (loss)     (7,169)   (278) (7,447)
Other comprehensive income (loss)       (880)   (880)
Ending balance at Mar. 31, 2021 $ 20 1,198,374 (685,265) (1,089) 9,066 521,106
Ending balance (in shares) at Mar. 31, 2021 199,815,018          
Beginning balance at Dec. 31, 2020 $ 20 1,191,791 (678,096) (209) 9,344 $ 522,850
Beginning balance (in shares) at Dec. 31, 2020 198,491,204         198,491,204
Increase (Decrease) in Stockholders' Equity            
Repurchase of common stock (in shares)           0
Net income (loss)         (560) $ (87,396)
Other comprehensive income (loss)           (164)
Ending balance at Jun. 30, 2021 $ 22 1,511,742 (764,932) (373) 8,784 $ 755,243
Ending balance (in shares) at Jun. 30, 2021 222,966,955         222,966,955
Beginning balance at Mar. 31, 2021 $ 20 1,198,374 (685,265) (1,089) 9,066 $ 521,106
Beginning balance (in shares) at Mar. 31, 2021 199,815,018          
Increase (Decrease) in Stockholders' Equity            
Issuance of common stock $ 2 194,171       $ 194,173
Issuance of common stock (in shares) 23,151,937          
Repurchase of common stock (in shares)           0
Stock-based compensation   3,419       $ 3,419
Stock-based sales incentive charges   115,778       115,778
Net income (loss)     (79,667)   (282) (79,949)
Other comprehensive income (loss)       716   716
Ending balance at Jun. 30, 2021 $ 22 $ 1,511,742 $ (764,932) $ (373) $ 8,784 $ 755,243
Ending balance (in shares) at Jun. 30, 2021 222,966,955         222,966,955